Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 65 (4), 1022-30

Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes

Affiliations

Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes

Massimo Porta et al. Diabetes.

Abstract

The risk of long-term diabetes complications is not fully explained by diabetes duration or long-term glycemic exposure, suggesting the involvement of genetic factors. Because thiamine regulates intracellular glucose metabolism and corrects for multiple damaging effects of high glucose, we hypothesized that variants in specific thiamine transporters are associated with risk of severe retinopathy and/or severe nephropathy because they modify an individual's ability to achieve sufficiently high intracellular thiamine levels. We tested 134 single nucleotide polymorphisms (SNPs) in two thiamine transporters (SLC19A2/3) and their transcription factors (SP1/2) for an association with severe retinopathy or nephropathy or their combination in the FinnDiane cohort. Subsequently, the results were examined for replication in the DCCT/EDIC and Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) cohorts. We found two SNPs in strong linkage disequilibrium in the SLC19A3 locus associated with a reduced rate of severe retinopathy and the combined phenotype of severe retinopathy and end-stage renal disease. The association for the combined phenotype reached genome-wide significance in a meta-analysis that included the WESDR cohort. These findings suggest that genetic variations in SLC19A3 play an important role in the pathogenesis of severe diabetic retinopathy and nephropathy and may explain why some individuals with type 1 diabetes are less prone than others to develop microvascular complications.

Trial registration: ClinicalTrials.gov NCT00360815 NCT00360893.

Figures

Figure 1
Figure 1
Forest plots of replication results and meta-analyses for lead SNPs in the analysis of DR and the combined phenotype. The point size of the diamonds and the squares are proportional to the precision of the estimates of OR. Results for rs6713116 behaved similarly. DCCT1, DCCT primary cohort; DCCT2, DCCT secondary cohort–conventional treatment; DCCT3, DCCT secondary cohort–intensive treatment.

Comment in

Similar articles

See all similar articles

Cited by 3 PubMed Central articles

Publication types

Substances

Associated data

Feedback